Company Filing History:
Years Active: 2017
Title: Chris DiBiasio: Innovator in Microfluidic Technology
Introduction
Chris DiBiasio is an accomplished inventor based in Stoughton, MA (US). He has made significant contributions to the field of medical technology, particularly in the area of blood filtration treatments. His innovative approach has the potential to enhance the efficacy of critical medical procedures.
Latest Patents
DiBiasio holds a patent for a microfluidic organ assist device incorporating boundary layer disrupters. This patent discusses a system and method aimed at improving blood filtration treatments such as hemodialysis, hemofiltration, and hemodiafiltration. The microfluidic device features first and second channels separated by a permeable membrane. One of these channels is designed for blood flow and includes a protein gel disruption layer. This layer contains multiple elements that extend across the blood flow channel, effectively reducing the formation of a boundary layer or gel layer at the blood-membrane interface.
Career Highlights
Chris DiBiasio is associated with Johnson & Johnson Innovation LLC, where he continues to develop groundbreaking technologies. His work focuses on enhancing medical devices that can significantly impact patient care and treatment outcomes.
Collaborations
DiBiasio has collaborated with notable professionals in his field, including Jeffrey T. Borenstein and Joseph L. Charest. These collaborations have further enriched his research and development efforts.
Conclusion
Chris DiBiasio is a key figure in the advancement of microfluidic technology, with a patent that addresses critical challenges in blood filtration treatments. His work at Johnson & Johnson Innovation LLC exemplifies his commitment to improving medical technology and patient care.